Pharma euphoria may reverse soon, and how!

Ipca’s export formulations business grew by 89 per cent to 1,500 crore. Sales of HCQ for the quarter totalled Rs 200 crore. The share price of Ipca in the past six months has risen by 27 per cent to Rs 2,034 from Rs 1,599. Shares of the other two companies have also risen by about a fifth since the pandemic struck.

from Markets-Economic Times https://ift.tt/2Yj2TRs
via IFTTT